Disease Area

huntington disease

Huntington Disease is an active area of clinical research and therapeutic development covered by The Life Science Feed. Our editorial team tracks the latest clinical trials, treatment guidelines, regulatory updates, and scientific advances relevant to Huntington Disease. Browse the latest articles below for in-depth analysis and evidence-based clinical insights.

Huntington Disease
What the tominersen failure taught Huntington disease drug development
The discontinuation of tominersen in Huntington disease trials highlighted the complexities of targeting mutant huntingtin protein and the need for refined therapeutic strategies.
Get the full story
10 min read
Huntington Disease
Managing chorea: balancing tetrabenazine, deutetrabenazine and psychiatric risk
Tetrabenazine and deutetrabenazine effectively reduce chorea in Huntington's disease, but clinicians must weigh their psychiatric adverse effects.
Get the full story
9 min read
Huntington Disease
AMT-130 in Huntington disease: What early gene therapy data really tell us
Early data on AMT-130 gene therapy for Huntington disease require careful interpretation, focusing on safety and target engagement rather than efficacy.
Get the full story
12 min read

Loading articles...